Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects
| Field | Value |
|---|---|
| Model ID | 11-038-01 |
| Model Name | Dorresteijn 2011 |
| Pubmed ID | 22090661 |
| First Author | Dorresteijn |
| Journal | European Heart Journal |
| Year | 2011 |
| Title | Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects |
| Primary Index Condition | Population Sample |
| Secondary Index Condition | N/A |
| Outcome | MACCE |
| Model Sample Size | 27939 |
| Cohort Sample Size | 27939 |
| Number of Events | 652 |
| Follow-Up Duration | Long (>6 months) |
| AUROC | 0.78 |
| Calibration Reported | 1 |
| Covariates | Intercept; Age in years; Age if using aspirin; Current smoker; Current smoker and using aspirin; Systolic blood pressure in mmHg; Total cholesterol in mmol/L; HDL cholesterol in mmol/L; High-sensitivity C-reactive protein in mg/dL; High-sensitivity C-reactive protein if using aspirin; Blood pressure lowering medication; Positive family history for premature myocardial infarction; Hemoglobin A1C (%) if diabetic; Aspirin; Body mass index (kg/m^2) if using aspirin |
| Mesh Terms | To be updated |
| Number of Validations | 0 |